Pfizer Wraps Up Haleon Exit With $3.3 Billion Stake Sale
Pfizer Inc. raised about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, culminating ...
Former L'Oréal Executive Nathalie Gerschtein Appointed CEO U.S.A and President North America at Consumer Health Company Haleon
Gerschtein is pivoting to the consumer health space after nearly 23 years in beauty at L'Oréal serving a variety of brands ...
FTSE 100 Live 19 March: Santander set to close 95 branches, Pfizer makes £2.5bn Haleon exit
Santander is to shut almost a quarter of its branch network in June, putting 750 jobs at risk. The Spanish owned high street ...
Sensodyne-maker axes diversity targets from bonuses
Haleon is to axe diversity targets from its executive bonus scheme in the latest sign that UK businesses are rowing back on ...
Pfizer sells entire Haleon stake for $3.24 billion
Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors ...
Pfizer (PFE) Bids Farewell to Haleon with $3.3B Final Stake Sale
Pfizer Inc. (PFE) agreed to sell its remaining stake worth $3.3 billion in Haleon PLC (HLN), marking its exit from the UK-based consumer ...
Zacks.com on MSN3d
Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B
Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...
Pfizer exits Haleon stake after $3.2B share sale
Pfizer (NYSE:PFE) has generated £2.5B ($3.24B) after selling its entire stake in Haleon (NYSE:HLN), the consumer healthcare ...